Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Collections

Filters ​

  • Collection |

    We provide a review of companies and trends being developed in the precision medicine field

    Image: Mark Garlick / Science Photo Library

  • Collection |

    In this collection we explore the companies and dealmaking trends driving the metabolic diseases market, focusing on obesity.

    Image: Iliescu Catalin / Alamy Stock Photo

  • Collection |

    In this spotlight, we discover more to Canada’s biotech scene by providing an overview of the market landscape and showcasing some of its innovative companies.

    Image: Bruce Yuanyue Bi

  • Collection |

    In this collection we follow the progress of key nucleic acid-based drugs, technologies and developing companies, whilst exploring the dealmaking trends driving these emerging therapeutics.

    Image: Kateryna Kon / Science Photo Library.

  • Collection |

    Discover what’s next in the world of antibodies and antibody–drug conjugates by reading about companies working in the field and identify the latest deals driving growth. Discover what’s next in the world of antibodies and antibody–drug conjugates by reading about companies working in the field and identify the latest deals driving growth.

    Image: Photo Library / Alamy Stock

  • Collection |

    We review the biopharma deals of 2024 made so far, as well as profiling active partnering companies developing pharma’s next innovations.

    Image: Witthaya Prasongsin/Getty

  • Collection |

    We explore the latest developments in the vaccines field, through our editorial feature and showcase of companies.

    Image: Syringe drawing liquid from a jar

  • Collection |

    Here we profile companies developing innovations for women’s health, a relatively underfunded market with few treatment options available for many conditions.

    Image: DigitalVision Vectors/Getty

  • Collection |

    Explore the latest progress in oncology drug development from both our company profiles and landscape feature that reviews the re-ignited interest in radiopharmaceuticals.

    Image: iStock / Getty Images Plus

Search

Advanced search

Quick links